It has been shown that DNMT1 stability is regulated by a mechanism involving in acetylation-driven ubiquitination [41], and HDAC inhibition promotes ubiquitin-dependent degradation of DNMT1 in breast cancer cells [42]. The gene discussed is HDAC9; the disease is breast cancer.